These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 14622241

  • 1. Quantitative analysis of dopaminergic loss in relation to functional territories in MPTP-treated monkeys.
    Jan C, Pessiglione M, Tremblay L, Tandé D, Hirsch EC, François C.
    Eur J Neurosci; 2003 Oct; 18(7):2082-6. PubMed ID: 14622241
    [Abstract] [Full Text] [Related]

  • 2. A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery.
    Mounayar S, Boulet S, Tandé D, Jan C, Pessiglione M, Hirsch EC, Féger J, Savasta M, François C, Tremblay L.
    Brain; 2007 Nov; 130(Pt 11):2898-914. PubMed ID: 17855373
    [Abstract] [Full Text] [Related]

  • 3. 14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease.
    Ding H, Underwood R, Lavalley N, Yacoubian TA.
    Neuroscience; 2015 Oct 29; 307():73-82. PubMed ID: 26314634
    [Abstract] [Full Text] [Related]

  • 4. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
    Petzinger GM, Fisher B, Hogg E, Abernathy A, Arevalo P, Nixon K, Jakowec MW.
    J Neurosci Res; 2006 Feb 01; 83(2):332-47. PubMed ID: 16385585
    [Abstract] [Full Text] [Related]

  • 5. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization.
    Shen YQ, Hebert G, Lin LY, Luo YL, Moze E, Li KS, Neveu PJ.
    J Neuroimmunol; 2005 Jan 01; 158(1-2):14-25. PubMed ID: 15589033
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of striatal D2 receptors in the MPTP-treated vervet monkey is reversed by grafts of fetal ventral mesencephalon: an autoradiographic study.
    Elsworth JD, Brittan MS, Taylor JR, Sladek JR, Redmond DE, Innis RB, Zea-Ponce Y, Roth RH.
    Brain Res; 1998 Jun 08; 795(1-2):55-62. PubMed ID: 9622593
    [Abstract] [Full Text] [Related]

  • 7. Dopaminergic cells in the periaqueductal grey matter of MPTP-treated monkeys and mice; patterns of survival and effect of deep brain stimulation and lesion of the subthalamic nucleus.
    Shaw VE, Keay KA, Ashkan K, Benabid AL, Mitrofanis J.
    Parkinsonism Relat Disord; 2010 Jun 08; 16(5):338-44. PubMed ID: 20227323
    [Abstract] [Full Text] [Related]

  • 8. Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies.
    Morissette M, Goulet M, Grondin R, Blanchet P, Bédard PJ, Di Paolo T, Lévesque D.
    Eur J Neurosci; 1998 Aug 08; 10(8):2565-73. PubMed ID: 9767387
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Sugama S, Wirz SA, Barr AM, Conti B, Bartfai T, Shibasaki T.
    Neuroscience; 2004 Aug 08; 128(2):451-8. PubMed ID: 15350655
    [Abstract] [Full Text] [Related]

  • 10. MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration.
    Pérez-Otaño I, Oset C, Luquin MR, Herrero MT, Obeso JA, Del Río J.
    Neurosci Lett; 1994 Jul 04; 175(1-2):121-5. PubMed ID: 7970192
    [Abstract] [Full Text] [Related]

  • 11. GSTpi expression in MPTP-induced dopaminergic neurodegeneration of C57BL/6 mouse midbrain and striatum.
    Castro-Caldas M, Neves Carvalho A, Peixeiro I, Rodrigues E, Lechner MC, Gama MJ.
    J Mol Neurosci; 2009 Jun 04; 38(2):114-27. PubMed ID: 18792812
    [Abstract] [Full Text] [Related]

  • 12. Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice.
    Vivacqua G, Biagioni F, Yu S, Casini A, Bucci D, D'Este L, Fornai F.
    J Chem Neuroanat; 2012 Jul 04; 44(2):76-85. PubMed ID: 22580273
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MPTP reduces dopamine and norepinephrine concentrations in the supplementary motor area and cingulate cortex of the primate.
    Elsworth JD, Deutch AY, Redmond DE, Sladek JR, Roth RH.
    Neurosci Lett; 1990 Jul 13; 114(3):316-22. PubMed ID: 2402341
    [Abstract] [Full Text] [Related]

  • 19. Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft.
    San Sebastián W, Guillén J, Manrique M, Belzunegui S, Ciordia E, Izal-Azcárate A, Garrido-Gil P, Vázquez-Claverie M, Luquin MR.
    Brain; 2007 May 13; 130(Pt 5):1306-16. PubMed ID: 17439984
    [Abstract] [Full Text] [Related]

  • 20. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L, Frohna PA, Joyce JN, Schneider JS.
    Mov Disord; 1997 Mar 13; 12(2):148-58. PubMed ID: 9087972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.